Intra-Cellular Therapies, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Intra-Cellular Therapies, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending June 30, 2024 was $4.51M, a 15.5% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.51M +$606K +15.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.97M +$67K +1.72% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.91M Dec 31, 2023 10-K 2024-02-22
Q3 2023 $3.91M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $3.91M Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.91M Mar 31, 2023 10-Q 2023-05-04
Q4 2019 $3.45M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $3.35M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $3.35M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $3.35M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.